Rocket Pharmaceuticals Announces Participation at Upcoming Conferences
|View printer-friendly version|
Evercore ISI HealthConX Conference
Gaurav Shah, M.D., Chief Executive Officer and President, will participate in a fireside chat on November 28, 2018, at 1:15 p.m. Eastern Timein Boston, MA
Barclays Gene Editing & Gene Therapy Summit
Dr. Shah will present on
November 29, 2018, at 11:15 a.m. Eastern Timein New York, NY
- Dr. Shah will present on
American Society of Hematology2018 Annual Meeting
Juan Bueren, Head of the Hematopoietic Innovative Therapies Division at CIEMAT in Spainand program principal investigator of the Phase 1/2 trial of RP-L102, will present the abstract “Advances in the Gene Therapy of Patients with Fanconi Anemia” in an oral session on December 3, 2018, at 6:30 p.m. Pacific Timein San Diego, CA.The presentation will include long-term follow up data from the first four patients treated, as presented at the 2018 Annual Congress of the European Society of Gene and Cell Therapyin October.
A live audio webcast of the Evercore ISI presentation will be available on the Investors section of the company’s website, www.rocketpharma.com. A replay of the presentation will be archived on the Rocket website following the conference.